Alimentiv Inc.

Academic / Other · 12 registered clinical trials — 5 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due Crohn Disease	Phase 4	2026-02-01
Recruiting	A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Trea Crohn Disease (CD)	N/A	2025-02-01
Recruiting	VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn	Phase 4	2024-08-07
Recruiting	Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participan Crohns Disease	—	2024-06-19
Recruiting	VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Crohn's Disease	—	2024-03-20
Suspended	Assessment of Patients With Acute Pouchitis Treated With Antibiotics Pouchitis, Ulcerative Colitis	—	2021-12-07
Terminated	Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis Ulcerative Colitis	—	2020-08-25
Active Not Recruiting	Determination of the Optimal Treatment Target in Ulcerative Colitis Colitis, Ulcerative	Phase 4	2020-02-18
Active Not Recruiting	Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Ulcerative Colitis	—	2018-12-21
Active Not Recruiting	Stopping Aminosalicylate Therapy in Inactive Crohn's Disease Crohn Disease, Remission	Phase 4	2017-11-20
Completed	Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy Crohn's Disease	Phase 4	2014-03-28
Terminated	Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) Ulcerative Colitis	Phase 2	2013-06-01